News Category: Health & Medical

— Features proprietary OXINIUM(TM) DH material; eliminates Cobalt Chrome alloy reducing wear and corrosion risks [1] Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in primary and revision hip arthroplasty in Japan. Compared with traditional solutions, dual mobility implants have a small diameter … Continued

– Bugworks – a US, India and Australia based start-up with globally recognized expertise in drug discovery, has set up a dedicated Immuno-oncology ex vivo research lab at the Bengaluru-based hospital, Cytecare. – The lab bridges the translation from discovery to development, addressing several hard-to-treat cancers such as gastric, colorectal, renal cell, breast, head and … Continued

The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch [ https://www.conceptmedical.com/product/magic-touch/ ] Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR). US FDA’s IDE approval allows the MagicTouch SCB [ https://www.conceptmedical.com/product/magic-touch/ ] to be used in a pivotal clinical study to support safety and effectiveness of this combination product. The data … Continued

Concept Medical (https://www.conceptmedical.com/) announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch (https://www.conceptmedical.com/product/magic-touch/) Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug Coated Balloon (DCB) in coronary artery disease (CAD) can … Continued

— The proprietary platform is versatile, equally effective with different cargoes, routes of administration Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced it has created a novel platform to safely and effectively deliver nucleic acid therapeutics – a major expansion of the company’s business. The eTurna … Continued

DarwinHealth, Inc., (www.DarwinHealth.com) a New York-based biotechnology and cancer drug discovery company announces the September 9, 2022 online publication in Current Protocols (Wiley Science) of their proprietary cancer drug discovery and validation pipeline, “A Patient-to-Model-to-Patient (PMP) cancer drug and biomarker discovery protocol for identifying and validating therapeutic agents targeting tumor regulatory architecture.” Logo – https://mma.prnewswire.com/media/966600/DarwinHealth_Logo.jpg … Continued

EpiVax, Inc. (“EpiVax”) is pleased to announce the award of a two-year, $2 million grant from the FDA’s Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) for improving biosimilar product development and assessing product interchangeability (# U01FD007760). The research will commence … Continued

LimaCorporate, a leading global orthopedic manufacturer focused on digital innovation and patient-tailored devices, today announces that Massimo Calafiore has been appointed by the Board of Directors as the new Chief Executive Officer of the company. Massimo’s appointment follows a thorough selection process that considered both internal and external candidates. Emmanuel Bonhomme, who has led the organization … Continued

Dental practices can use the tools as a guide to make their work more environmentally sustainable and by tracking progress they can achieve recognition awards for their efforts. FDI World Dental Federation (FDI) today launched a Toolkit for Sustainable Dentistry[https://www.sustainability-platform.fdiworlddental.org/], to help dental practices understand what actions they can take to ensure their work is … Continued